Page 4 - INTERIM NEWSLETTER FINAL

Brexit process is being monitored and solutions on the management of collaboration with UK
partners in the future have been taken into account.

3

EU COMMISSION FOR GAPP

DG SANTE representative summarised the high-level findings discussed during the Evaluation
process of EU directives and why GAPP JA is very important for the Commission. During the
Evaluation report presentation, there was a broad consensus on the document (available at the

link https://ec.europa.eu/health/sites/health/files/blood_tissues_organs/docs/swd_2019_376_en.pdf)
summarising the evaluation of directives 2002/98 for Blood and 2004/23 for Tissues and Cells,

This report is part of the project/joint action ‘785269/GAPP’ which has received funding from the European Union’s Health Programme (2014-2020). The content of this report represents the views of
the author only and is his/her sole responsibility; it can not be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any
other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
GAPP JA | Deliverable 0.0